Domestic pharmaceutical industry faces murky economic outlook

Market analysts said that confronted with the increasing dismal outlook, a number of pharmaceutical firms have reportedly failed to achieve their sales target in the first quarter of this year due to sluggish sales in the ethical and OTC market, and their possible turnover achievement this year is unlikely in the face of the mounting geopolitical worries that the war in Iraq may take longer tha...